Biogenic amine hypotheses of affective disorders.
D000342:Affective Symptoms / Q000503:physiopathology*; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001679:Biogenic Amines / Q000378:metabolism / Q000502:physiology*; D001714:Bipolar Disorder / Q000378:metabolism; D003863:Depression / Q000139:chemically induced / Q000378:metabolism; D004597:Electroshock; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008566:Membranes / Q000378:metabolism; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D009638:Norepinephrine